BI-456906

BI-456906 is a synthetic peptide-based dual agonist studied in non-human models for its activity at glucagon receptor (GCGR) and glucagon-like peptide-1 receptor (GLP-1R) signaling pathways. Scientific literature examines this compound in the context of receptor co-activation and its downstream effects on metabolic signaling, energy substrate regulation, and related pathway behavior in research systems.

Research applications commonly explored in the literature include:

Dual GCGR/GLP-1R receptor co-activation modeling

Metabolic signaling pathway investigation in non-human research systems

Energy homeostasis and substrate utilization research models

Comparative receptor agonism studies within incretin-related signaling frameworks

Adipose and hepatic tissue signaling research in controlled non-human models

The lyophilized vial format allows researchers to evaluate compound stability, reconstitution characteristics, and handling parameters within controlled laboratory settings, supporting consistency across experimental preparation. Each BI-456906 10 mg vial from KÖLD is prepared and filled in the United States under sterile laboratory conditions. All batches are verified by independent third-party laboratories for purity, volume accuracy, and molecular identity.

1. What is BI-456906 studied for in research settings?
BI-456906 appears in scientific literature as a dual agonist targeting glucagon receptors (GCGR) and GLP-1 receptors simultaneously. Research focuses on how simultaneous activation of these two receptor pathways influences downstream metabolic and energy-related signaling in non-human models.

2. How does BI-456906 differ from single-receptor GLP-1 agonists in research contexts?
Unlike compounds that selectively target GLP-1R alone, BI-456906 is studied for its dual-receptor activity. Scientific literature explores whether co-activation of GCGR alongside GLP-1R produces distinct signaling outcomes compared to single-receptor agonism, making it a useful tool compound in receptor pharmacology research.

3. Why is BI-456906 provided in a lyophilized vial format?
The lyophilized format supports compound stability, extended storage, and controlled handling during research preparation. This format allows researchers to evaluate reconstitution behavior under consistent laboratory conditions.

4. Is BI-456906 approved for any use in humans or animals?
No. BI-456906 is not approved for human or veterinary use. All products sold by KÖLD are strictly for in vitro and non-human laboratory research purposes only.

5. How is purity and quality verified?
Each BI-456906 10 mg vial undergoes independent third-party laboratory testing to confirm molecular identity, purity, and volume accuracy prior to release.

Before Reconstitution

Store sealed vial in a freezer at -20°C (–4°F)

Keep away from light and humidity

After Reconstitution

Store at 4°C (39°F)

Use within 14 days

Avoid repeated freeze-thaw cycles

This compound is supplied as a lyophilized powder.
Use KÖLD Solution (sterile, lab-grade solvent) if your protocol requires reconstitution.
Reconstitute only when ready to begin your study.
For research use only. Not for human or animal use.
Not intended to diagnose, treat, cure, or prevent any disease.